• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症免疫治疗的靶向自然杀伤细胞和CD8 T细胞的手性纳米颗粒的研发

The Development of Chiral Nanoparticles to Target NK Cells and CD8 T Cells for Cancer Immunotherapy.

作者信息

Wang Weiwei, Zhao Jing, Hao Changlong, Hu Shudong, Chen Chen, Cao Yi, Xu Zhengyu, Guo Jun, Xu Liguang, Sun Maozhong, Xu Chuanlai, Kuang Hua

机构信息

International Joint Research Laboratory for Biointerface and Biodetection, State Key Lab of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, P. R. China.

Department of Radiology, Affiliated Hospital, Jiangnan University, Wuxi, Jiangsu, 214122, P. R. China.

出版信息

Adv Mater. 2022 Apr;34(16):e2109354. doi: 10.1002/adma.202109354. Epub 2022 Mar 10.

DOI:10.1002/adma.202109354
PMID:35176181
Abstract

The chirality of nanomaterials (nanoparticles, NPs) can influence their interaction with cells and biological systems. However, how chirality can exert impact on the immune response has yet to be investigated. Here, the immunological effect of chiral nanomaterials is investigated as a therapeutic and preventive option against tumors. Compared with achiral nanoparticles, chiral NPs with a g-factor of 0.44 are shown to enhance both innate and acquired immunity against tumor growth. It is also found that chiral NPs enhance the activation of CD8 T and natural killer cells (CD69 NK cells) by stimulating dendritic cells (DCs). Importantly, L-type NPs induce a 1.65-fold higher proportion of CD8 T and CD69 NK cells than D-type NPs. Next, the therapeutic and preventative effects of chiral NPs against tumors in a EG7.OVA tumor model are investigated. It is found that L-type NPs have a significant greater ability to induce apoptosis in tumor cells and prolong the survival time of model mice than D-type NPs. Mice treated with L-type NPs induce the activation of 84.98 ± 6.63% CD8 T cells and 33.62 ± 3.41% of NK cells in tumor tissues; these are 1.62-fold and 1.39-fold higher than that seen in the mice treated with D-type NPs. Mechanistic studies reveal that chiral NPs exert mechanical force on bone-marrow-derived dendritic cells (BMDCs) and stimulate the expression of cytokines to induce cytotoxic activity in NK cells. Synergistically, the CD8 T cells are stimulated to eliminate tumor cells via antigen cross presentation. The force of interaction between L-type NPs and cells is higher than that for D-NPs, thus further promoting the activation of NK cells and CD8 T cells and their infiltration into tumor tissue. These findings open up a new avenue for chiral nanomaterials to act as immunoadjuvants for the prevention and treatment of cancer.

摘要

纳米材料(纳米颗粒,NPs)的手性能够影响它们与细胞及生物系统的相互作用。然而,手性如何对免疫反应产生影响还有待研究。在此,研究了手性纳米材料的免疫效应,将其作为一种针对肿瘤的治疗和预防手段。与非手性纳米颗粒相比,g因子为0.44的手性NPs显示出能增强针对肿瘤生长的固有免疫和获得性免疫。还发现手性NPs通过刺激树突状细胞(DCs)增强CD8 T细胞和自然杀伤细胞(CD69 NK细胞)的活化。重要的是,L型NPs诱导产生的CD8 T细胞和CD69 NK细胞比例比D型NPs高1.65倍。接下来,研究了手性NPs在EG7.OVA肿瘤模型中对肿瘤的治疗和预防作用。发现L型NPs比D型NPs具有显著更强的诱导肿瘤细胞凋亡及延长模型小鼠存活时间的能力。用L型NPs处理的小鼠在肿瘤组织中诱导84.98±6.63%的CD8 T细胞和33.62±3.41%的NK细胞活化;这些比例分别比用D型NPs处理的小鼠高1.62倍和1.39倍。机制研究表明,手性NPs对骨髓来源的树突状细胞(BMDCs)施加机械力并刺激细胞因子表达以诱导NK细胞的细胞毒活性。协同地,CD8 T细胞被刺激通过抗原交叉呈递消除肿瘤细胞。L型NPs与细胞之间的相互作用力高于D型NPs,从而进一步促进NK细胞和CD8 T细胞的活化及其向肿瘤组织的浸润。这些发现为手性纳米材料作为癌症预防和治疗的免疫佐剂开辟了一条新途径。

相似文献

1
The Development of Chiral Nanoparticles to Target NK Cells and CD8 T Cells for Cancer Immunotherapy.用于癌症免疫治疗的靶向自然杀伤细胞和CD8 T细胞的手性纳米颗粒的研发
Adv Mater. 2022 Apr;34(16):e2109354. doi: 10.1002/adma.202109354. Epub 2022 Mar 10.
2
Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.用于增强免疫反应的聚合物纳米颗粒:肿瘤抗原与小干扰RNA联合递送至树突状细胞以抑制免疫基因
Acta Biomater. 2014 May;10(5):2169-76. doi: 10.1016/j.actbio.2013.12.050. Epub 2014 Jan 4.
3
Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8 T Cell Memory and Delayed Tumor Progression.聚酸酐纳米粒子诱导低炎症性树突状细胞激活,导致 CD8 T 细胞记忆和肿瘤进展延迟。
Int J Nanomedicine. 2020 Sep 7;15:6579-6592. doi: 10.2147/IJN.S261041. eCollection 2020.
4
Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells.用于联合免疫调节、抗原呈递和免疫治疗细胞跟踪的可编程纳米颗粒。
Biomaterials. 2014 Jan;35(1):590-600. doi: 10.1016/j.biomaterials.2013.10.009. Epub 2013 Oct 11.
5
Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.通过功能化海藻酸钠纳米粒靶向递送至树突状细胞用于癌症免疫治疗。
J Control Release. 2017 Jun 28;256:170-181. doi: 10.1016/j.jconrel.2017.04.020. Epub 2017 Apr 13.
6
Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 T cells.经工程改造表达膜结合抗原的外膜囊泡可对树突状细胞进行交叉呈递,以激活 CD8 T 细胞。
Acta Biomater. 2019 Jun;91:248-257. doi: 10.1016/j.actbio.2019.04.033. Epub 2019 Apr 17.
7
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.聚(d,l-丙交酯-共-乙交酯)纳米颗粒通过Toll样受体3诱导免疫反应用于基于树突状细胞的癌症免疫治疗
Int J Nanomedicine. 2016 Nov 2;11:5729-5742. doi: 10.2147/IJN.S109001. eCollection 2016.
8
Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.用于外源抗原交叉呈递和增强细胞毒性T淋巴细胞免疫反应的聚合物纳米颗粒。
Int J Nanomedicine. 2016 Aug 5;11:3753-64. doi: 10.2147/IJN.S110796. eCollection 2016.
9
Natural killer-dendritic cell cross-talk in cancer immunotherapy.癌症免疫治疗中自然杀伤细胞与树突状细胞的相互作用
Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. doi: 10.1517/14712598.5.10.1303.
10
Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.重组脂化 Survivin 通过抗原呈递细胞的有效摄取引发抗原交叉呈递和抗肿瘤免疫。
Front Immunol. 2018 Apr 23;9:822. doi: 10.3389/fimmu.2018.00822. eCollection 2018.

引用本文的文献

1
Natural killer cell-based immunotherapies for colorectal cancer: Current strategies, challenges, and future perspectives.基于自然杀伤细胞的结直肠癌免疫疗法:当前策略、挑战及未来展望。
World J Gastroenterol. 2025 Sep 14;31(34):110051. doi: 10.3748/wjg.v31.i34.110051.
2
Chiral gold nanoparticles manipulate osteoimmune microenvironment via macrophage autophagy for bone regeneration.手性金纳米颗粒通过巨噬细胞自噬调控骨免疫微环境以促进骨再生。
Mater Today Bio. 2025 Jul 25;34:102131. doi: 10.1016/j.mtbio.2025.102131. eCollection 2025 Oct.
3
Enantioselective synthesis of chiroplasmonic helicoidal nanoparticles by nanoconfinement in chiral dielectric shells.
通过在手性介电壳层中进行纳米限域实现手性等离子体螺旋纳米粒子的对映选择性合成。
Nat Commun. 2025 Mar 11;16(1):2418. doi: 10.1038/s41467-025-57624-w.
4
Recent Advances in Chiral Gold Nanomaterials: From Synthesis to Applications.手性金纳米材料的最新进展:从合成到应用
Molecules. 2025 Feb 11;30(4):829. doi: 10.3390/molecules30040829.
5
Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response.手性多肽水凝胶调节局部免疫微环境和抗肿瘤免疫反应。
Nat Commun. 2025 Jan 31;16(1):1222. doi: 10.1038/s41467-025-56137-w.
6
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.癌症纳米免疫疗法的现状与未来:机遇、障碍与挑战
Mol Cancer. 2025 Jan 18;24(1):26. doi: 10.1186/s12943-024-02214-5.
7
Chiral plasmonic-dielectric coupling enables strong near-infrared chiroptical responses from helicoidal core-shell nanoparticles.手性等离子体-介电耦合使螺旋核壳纳米粒子产生强烈的近红外手性光学响应。
Nat Commun. 2024 Oct 25;15(1):9234. doi: 10.1038/s41467-024-53705-4.
8
Considering the impact of the chirality of therapeutic nanoparticles on cancer therapy.考虑治疗性纳米粒子的手性对癌症治疗的影响。
Nanomedicine (Lond). 2024;19(28):2331-2334. doi: 10.1080/17435889.2024.2403320. Epub 2024 Sep 24.
9
Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways.基于自然杀伤细胞的疗法:关于与多样化药物递送途径相关的癌症治疗的前瞻性思考。
Pharmaceutics. 2024 Jul 14;16(7):939. doi: 10.3390/pharmaceutics16070939.
10
Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer.干扰素调节因子1在非小细胞肺癌中的临床意义及生物学功能
Front Pharmacol. 2024 Jun 10;15:1413699. doi: 10.3389/fphar.2024.1413699. eCollection 2024.